**Core Concept**
Hepatorenal syndrome (HRS) is a type of progressive kidney dysfunction that occurs in individuals with advanced liver disease, typically cirrhosis. It is characterized by a significant reduction in renal function, leading to acute kidney injury. The exact pathophysiology of HRS is not fully understood, but it is believed to involve a combination of factors, including decreased hepatic blood flow, splanchnic vasodilation, and activation of various vasoconstrictor systems.

**Why the Correct Answer is Right**
Hepatorenal syndrome is characterized by a triad of findings: (1) a significant increase in serum creatinine (≥ 1.5 times the baseline value), (2) a decrease in urine sodium (< 10 mmol/L), and (3) the absence of other causes of kidney dysfunction. This syndrome is often seen in patients with advanced liver disease, particularly those with cirrhosis, and is associated with a poor prognosis. The pathophysiology of HRS is complex and involves the activation of various vasoconstrictor systems, including the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system. **Why Each Wrong Option is Incorrect** **Option A:** This option is not explicitly stated in the question, so I will move on to the next option. **Option B:** This option is not a characteristic of hepatorenal syndrome. HRS is characterized by an increase in serum creatinine, not a decrease. **Option C:** This option is not a characteristic of hepatorenal syndrome. HRS is characterized by a decrease in urine sodium, not an increase. **Clinical Pearl / High-Yield Fact** Hepatorenal syndrome is a medical emergency that requires prompt recognition and treatment. The diagnosis of HRS is based on the presence of a significant increase in serum creatinine, a decrease in urine sodium, and the absence of other causes of kidney dysfunction. Early recognition and treatment of HRS can improve outcomes and reduce mortality. **Correct Answer: B. This option is not a characteristic of hepatorenal syndrome. HRS is characterized by an increase in serum creatinine, not a decrease.**